- Product Details
Keywords
- 19241-16-8
- 2,6-Dimethylphenyl isothiocyanate
- 2,6-DIMETHYLPHENYL ISOTHIOCYANATE
Quick Details
- ProName: 2,6-Dimethylphenyl isothiocyanate
- CasNo: 19241-16-8
- Molecular Formula: C9H9NS
- Appearance: white or yellowish white flaky crystal
- Application: Used for research and industrial manuf...
- DeliveryTime: Within7-10 days after receipt of your ...
- PackAge: As customer request
- Port: Qingdao,China
- ProductionCapacity: 100 Metric Ton/Day
- Purity: 98%min
- Storage: Keep the sun from direct sunlight ;pre...
- Transportation: By Sea/Air/Courier
- LimitNum: 100 Metric Ton
Superiority
Lorcaserin(856681-05-5)is an orally administered agent and a selective 5-HT2C receptor agonist for the treatment of obesity. It had been approved for marketing in US by FDA on 27 June in 2012. In clinical studies, lorcaserin has demonstrated efficacy in obese and overweight populations by promoting weight loss and improving metabolic parameters, and it is well tolerated.
Details
,6-DIMETHYLPHENYL ISOTHIOCYANATE Basic information |
Product Name: | 2,6-DIMETHYLPHENYL ISOTHIOCYANATE |
Synonyms: | 2,6-DIMETHYLPHENYL ISOTHIOCYANATE;2,6-Dimethylphenyl-1-isothiocyanate;2,6-Xylyl isothiocyanate;2-Isothiocyanato-1,3-dimethylbenzene;Benzene, 2-isothiocyanato-1,3-dimethyl-;Isothiocyanic acid, 2,6-xylyl ester;2,6-Dimethylphenyl isothiocyanate,98%;2,6-Dimethylphenyl isothiocyanate 98% |
CAS: | 19241-16-8 |
MF: | C9H9NS |
MW: | 163.24 |
EINECS: | 242-906-0 |
Product Categories: | Organic Building Blocks;Sulfur Compounds;Thiocyanates/Isothiocyanates |
Mol File: | 19241-16-8.mol |
2,6-DIMETHYLPHENYL ISOTHIOCYANATE Chemical Properties |
bp | 247 °C(lit.) |
density | 1.085 g/mL at 25 °C(lit.) |
refractive index |
n |
Fp | >230 °F |
Sensitive | Moisture Sensitive |
BRN | 637195 |
CAS DataBase Reference | 19241-16-8(CAS DataBase Reference) |
Safety Information |
Hazard Codes | Xn,C,Xi |
Risk Statements | 22-36/37/38-43 |
Safety Statements | 26-36 |
RIDADR | 2810 |
WGK Germany | 3 |
HazardClass | 6.1 |
PackingGroup |
III |